WCG Talks Trials
WCG Talks Trials
WCG
An Inside Look at Angelman Syndrome Rare Disease: An Interview with Amanda Moore
18 minutes Posted Jan 13, 2020 at 8:00 pm.
0:00
18:52
Download MP3
Show notes

In this episode, Amanda Moore, CEO of Angelman Syndrome Foundation speaks with Steve Smith, WCG’s President of Patient Advocacy. As a mom whose son has been diagnosed with Angelman Syndrome - a rare neuro-genetic disorder that affects 1 in 15,000 children - Amanda walks through the time from receiving initial diagnosis to the odyssey of her son’s patient journey in therapy and clinical trials.